Novel substituted 5-methyl-4-acylaminoisoxazoles as antimitotic agents: Evaluation of selectivity to LNCaP cancer cells.
Arch Pharm (Weinheim)
; 355(5): e2100425, 2022 May.
Article
em En
| MEDLINE
| ID: mdl-35103336
Palavras-chave
Texto completo:
1
Bases de dados:
MEDLINE
Assunto principal:
Antimitóticos
/
Neoplasias
/
Antineoplásicos
Limite:
Humans
Idioma:
En
Revista:
Arch Pharm (Weinheim)
Ano de publicação:
2022
Tipo de documento:
Article